To determine if the impact of IP-10 on dormant breast cancer cells occurs directly or indirectly, we assessed tumor proliferation following exposure to proportionate levels of IP-10 used in the ex vivo metastatic liver MPS. Here, CXCL10 is linked to neoplasm.